Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis
Articolo
Data di Pubblicazione:
2018
Abstract:
Cytoreduction is sometimes an important aim of systemic anti-tumor therapies in well-differentiated pancreatic neuroendocrine tumors (PanNETs). As there is not a gold standard treatment for these tumors in this field, we conducted a literature review in order to identify objective criteria for treatment choice.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Cytoreduction; Cytoreductive treatments; Pancreatic NET; Tumor response rate; Tumor shrinkage; Well-differentiated pancreatic neuroendocrine tumors
Elenco autori:
Pozzari, M; Maisonneuve, P; Spada, F; Berruti, A; Amoroso, V; Cella, CHIARA ALESSANDRA; Laffi, A; Pellicori, S; Bertani, E; Fazio, N.
Link alla scheda completa:
Pubblicato in: